By Nancy Lapid April 17 (Reuters) - Researchers have developed a modified version of the CRISPR gene-editing tool that in ...
Drug development is aiming to move from managing disease to correcting it through RNA and gene-editing therapies. But ...
After Replimune’s advanced melanoma drug was rejected for a second time, CEO Sushil Patel slammed the FDA for failing to ...
Morning Overview on MSN
Compact CRISPR tool boosts in-body gene editing to 90% in lab tests
For the millions of people living with genetic diseases like muscular dystrophy and inherited liver disorders, one of the ...
Boston researchers Stuart Orkin and Lee Roberts were honored with one of the six Breakthrough Prizes for achievements in life ...
For the first time, a research team at the Leibniz Institute of Plant Genetics and Crop Plant Research (IPK) has succeeded in ...
Imagination pairs with plant breeding innovation using tools such as gene editing and cyber agriculture to redefine ...
The US Food and Drug Administration released a draft guidance document on Tuesday with recommendations for using ...
Scientists have taken an important step toward a gene therapy that could one day turn off the extra genetic material that ...
This guidance emphasises the potential of NGS methods in mitigating safety risks associated with therapies incorporating ...
The ACC has published a scientific statement regarding the use of gene editing therapy for cardiovascular disease.
BioNTech has a rich pipeline that could help jolt the stock as it makes clinical progress. Intellia Therapeutics faces ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results